SKAN Group AG
SKAN Group AG (SKAN.SW) Stock Overview
Explore SKAN Group AG’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.6B
P/E Ratio
42.01
EPS (TTM)
$1.73
ROE
0.21%
SKAN.SW Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of SKAN Group AG (SKAN.SW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 55.76, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $74.82.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 42.01 and a market capitalization of 1.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
SKAN Group AG provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Asia, Europe, the Americas, and internationally. It operates in two segments: Equipment and Solutions (E&S) and Services and Consumables (S&C). The E&S segment offers mission-critical solutions for the pharmaceutical production, including isolators, integrated automated systems, and aseptic filling systems and solutions, as well as laboratory and cleanroom equipment. The S&C segment provides life cycle support and ready-to-use consumables, as well as customer- specific and digital solutions. The company was formerly known as BV Holding AG and changed its name to SKAN Group AG in October 2021. SKAN Group AG was founded in 1968 and is headquartered in Allschwil, Switzerland.
Thomas Huber
1,377
Kreuzstrasse 5, Allschwil
2021